Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: an update of what we now know

L Yip, N Rufaut, R Sinclair - Australasian Journal of …, 2011 - Wiley Online Library
The role of genetic predisposition and the influence of sex steroid hormones are
indisputable to the pathogenesis of male androgenetic alopecia (MAGA). The role of sex …

[HTML][HTML] Role of genetic polymorphisms and ovarian cancer susceptibility

PA Fasching, S Gayther, L Pearce, JM Schildkraut… - Molecular …, 2009 - Elsevier
The value of identifying women with an inherited predisposition to epithelial ovarian cancer
has become readily apparent with the identification of the BRCA1, and BRCA2 genes …

Genetic determinants of circulating estrogen levels and evidence of a causal effect of estradiol on bone density in men

AL Eriksson, JRB Perry, AD Coviello… - The Journal of …, 2018 - academic.oup.com
Context Serum estradiol (E2) and estrone (E1) levels exhibit substantial heritability.
Objective To investigate the genetic regulation of serum E2 and E1 in men. Design, Setting …

Gene‐wide association study between the aromatase gene (CYP19A1) and female pattern hair loss

L Yip, S Zaloumis, D Irwin, G Severi… - British Journal of …, 2009 - academic.oup.com
Background Female pattern hair loss (FPHL) is a common trait in which androgens and
oestrogens may have a pathogenic role. The aromatase enzyme converts androgens to …

Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women

TJ Key - Steroids, 2011 - Elsevier
Breast cancer risk is strongly related to several reproductive and hormonal factors, but the
nature of the effects of endogenous oestrogens has been difficult to establish. Data are now …

CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer

DJ Thompson, TA O'mara, DM Glubb… - Endocrine-related …, 2015 - pmc.ncbi.nlm.nih.gov
Candidate gene studies have reported CYP19A1 variants to be associated with endometrial
cancer and with estradiol (E2) concentrations. We analyzed 2937 single nucleotide …

[HTML][HTML] Classification of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective …

F Laroche, J Coste, T Medkour, PH Cottu, JY Pierga… - The Journal of …, 2014 - Elsevier
Aromatase inhibitors (AIs) are the first-line treatment in women with breast cancer for total
estrogen depletion. Half the treated women may develop pain, and this condition may …

SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials

B Conte, L Boni, G Bisagni, A Durando, G Sanna… - Clinical Cancer …, 2023 - AACR
Purpose: In estrogen receptor–positive (ER+) breast cancer, single-nucleotide
polymorphisms (SNP) in the aromatase gene might affect aromatase inhibitors (AI) …

Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors

JJ Mao, HI Su, R Feng, ML Donelson, R Aplenc… - Breast Cancer …, 2011 - Springer
Introduction Aromatase inhibitor-associated arthralgia (AIAA) is a common and often
debilitating symptom in breast cancer survivors. Since joint symptoms have been related to …

Genome-wide association study of age at menarche in African-American women

EW Demerath, CT Liu, N Franceschini… - Human molecular …, 2013 - academic.oup.com
African-American (AA) women have earlier menarche on average than women of European
ancestry (EA), and earlier menarche is a risk factor for obesity and type 2 diabetes among …